Epigenomics AG (XTER:ECX)
€ 0.7 -0.088 (-11.17%) Market Cap: 490,000.00 Enterprise Value: -2.74 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 45/100

Nine Months 2019 Epigenomics AG Earnings Call Transcript

Nov 19, 2019 / 02:30PM GMT
Release Date Price: €200.06 (+9.44%)
Operator

Good afternoon, ladies and gentlemen. Welcome to the Epigenomics AG Conference Call regarding the 9-month Results of 2019. (Operator Instructions)

Let me now turn the floor over to Mr. Frederic Hilke.

Frederic Hilke
Epigenomics AG - IR Officer

Thank you very much, Hannah. Hello, and welcome to the conference call for the financial results of the first 9 months of 2019. My name is Frederic Hilke, I'm the Investor Relations Manager for Epigenomics.

With me on the phone is the CEO of Epigenomics AG, Greg Hamilton. Before I hand over the presentation to Greg, let me point out some of the usual legal information. The following presentation will contain expressly or implicitly certain forward-looking statements concerning Epigenomics AG and its business. Such statements involve certain known and unknown risks, uncertainties and other factors, which could cause the actual results, financial condition, performance or achievements of Epigenomics AG to be materially different from any future results, performance or achievements expressed or implied by

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot